This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Université De Haute-Alsace. Active years: 2013.
Company Filing History:

Years Active: 2013
Title: Christelle Delaite: Innovator in Nanoparticle Technology
Introduction
Christelle Delaite is a prominent inventor based in Froeningen, France. She has made significant contributions to the field of nanoparticle technology, particularly in the development of materials that have important applications in medical imaging.
Latest Patents
Delaite holds a patent for the "Preparation of poly(ethylene oxide)-coated nanoparticles of maghemite." This invention relates to a material consisting of an aqueous dispersion of PEG-coated nanoparticles of maghemite. The process for preparing this material involves polymerizing ethylene oxide in the presence of nanoparticles of maghemite in an aqueous dispersion. The polymerization is initiated using reactive groups capable of initiating the polymerization of ethylene oxide without the addition of a catalyst. These reactive groups are attached to the nanoparticles of maghemite through a coupling agent that includes an alkoxysilyl group. This innovative material has applications as a contrast agent for MRI.
Career Highlights
Throughout her career, Christelle Delaite has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Haute-Alsace. Her work has focused on advancing the understanding and application of nanoparticle technology in various fields.
Collaborations
Delaite has collaborated with notable colleagues, including Philippe Dumas and Christophe Flesch. These partnerships have contributed to her research and the successful development of her patented technologies.
Conclusion
Christelle Delaite is a trailblazer in the field of nanoparticle technology, with her innovative work paving the way for advancements in medical imaging. Her contributions are significant and continue to impact the scientific community.